Characteristics and Prognosis for Molecular Breast Cancer Subtypes in Chinese Women

被引:46
作者
Zhao, Jing [1 ,2 ,3 ]
Liu, Hong [1 ]
Wang, Meng [4 ]
Gu, Lin [1 ]
Guo, Xiaojing [2 ,3 ]
Gu, Feng [2 ,3 ]
Fu, Li [1 ,2 ,3 ]
机构
[1] Tian Jin Med Univ, Dept Breast Canc, Canc Inst & Hosp, Tianjin 300060, Peoples R China
[2] Tian Jin Med Univ, Dept Breast Canc Pathol, Canc Inst & Hosp, State Key Lab Breast Canc Res, Tianjin 300060, Peoples R China
[3] Tian Jin Med Univ, Res Lab, Canc Inst & Hosp, State Key Lab Breast Canc Res, Tianjin 300060, Peoples R China
[4] Tian Jin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Tianjin 300060, Peoples R China
关键词
molecular subtypes; risk factor; clinicopathological feature; Chinese population; BASAL-LIKE SUBTYPE; DISTANT METASTASIS; ESTROGEN-RECEPTOR; EXPRESSION; CARCINOMAS; BRCA1; PREVALENCE; MUTATIONS; PHENOTYPE; SURVIVAL;
D O I
10.1002/jso.21307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer is regarded its it heterogeneous disease with four molecular subtypes. However, the clinicopathological characteristics among the different subtypes have not been Studied in Chinese demographic. This study clarifies the prevalence and clinicopathological features of each Subtype and investigates the independent prognosis Factors in the Chinese population. Methods: A retrospective review of 1,820 Chinese breast cancer women were classified into different molecular subtypes based oil the IHC-based definitions for ER, PR, and HER-2/neu to evaluate the clinicopathological features and prognosis. Results: Luminal A subtype was the most prevalent with the oldest medium age at first full-term birth. The basal cell-like subtype was associated with early onset, higher percentage of node positivity. family history of breast cancer, increased tumor size. advanced turner grade. higher prevalence in the premenopausal group and the earlier age at menarche. Univariate and multivariate analysis of OS and RFS identified the basal cell-like and HER-2/neu subtypes as negative prognostic factors. A family history was in independent predictor of shorter RFS and OS in only the basal cell-like Subtype. Conclusions: The basal cell-like Subtype is associated with it poor prognosis and a family history was it negative predictor in the basal cell-like subtype. J. Surg. Oncol. 2009;100:89-94. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 31 条
[21]   Molecular portraits of human breast tumours [J].
Perou, CM ;
Sorlie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Rees, CA ;
Pollack, JR ;
Ross, DT ;
Johnsen, H ;
Akslen, LA ;
Fluge, O ;
Pergamenschikov, A ;
Williams, C ;
Zhu, SX ;
Lonning, PE ;
Borresen-Dale, AL ;
Brown, PO ;
Botstein, D .
NATURE, 2000, 406 (6797) :747-752
[22]   Prognostic relevance of basal cytokeratin expression in operable breast cancer [J].
Potemski, P ;
Kusinska, R ;
Watala, C ;
Pluciennik, E ;
Bednarek, AK ;
Kordek, R .
ONCOLOGY, 2005, 69 (06) :478-485
[23]   Prognostic markers in triple-negative breast cancer [J].
Rakha, Emad A. ;
El-Sayed, Maysa E. ;
Green, Andrew R. ;
Lee, Andrew H. S. ;
Robertson, John F. ;
Ellis, Ian O. .
CANCER, 2007, 109 (01) :25-32
[24]   The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer [J].
Rolland, Phil ;
Spendlove, Ian ;
Madjid, Zahra ;
Rakha, Emad A. ;
Patel, Poulam ;
Eljis, Ian O. ;
Durrant, Lindy .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) :1311-1317
[25]   Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J].
Rouzier, R ;
Perou, CM ;
Symmans, WF ;
Ibrahim, N ;
Cristofanilli, M ;
Anderson, K ;
Hess, KR ;
Stec, J ;
Ayers, M ;
Wagner, P ;
Morandi, P ;
Fan, C ;
Rabiul, I ;
Ross, JS ;
Hortobagyi, GN ;
Pusztai, L .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5678-5685
[26]   Repeated observation of breast tumor subtypes in independent gene expression data sets [J].
Sorlie, T ;
Tibshirani, R ;
Parker, J ;
Hastie, T ;
Marron, JS ;
Nobel, A ;
Deng, S ;
Johnsen, H ;
Pesich, R ;
Geisler, S ;
Demeter, J ;
Perou, CM ;
Lonning, PE ;
Brown, PO ;
Borresen-Dale, AL ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8418-8423
[27]   Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications [J].
Sorlie, T ;
Perou, CM ;
Tibshirani, R ;
Aas, T ;
Geisler, S ;
Johnsen, H ;
Hastie, T ;
Eisen, MB ;
van de Rijn, M ;
Jeffrey, SS ;
Thorsen, T ;
Quist, H ;
Matese, JC ;
Brown, PO ;
Botstein, D ;
Lonning, PE ;
Borresen-Dale, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10869-10874
[28]   Breast cancer classification and prognosis based on gene expression profiles from a population-based study [J].
Sotiriou, C ;
Neo, SY ;
McShane, LM ;
Korn, EL ;
Long, PM ;
Jazaeri, A ;
Martiat, P ;
Fox, SB ;
Harris, AL ;
Liu, ET .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10393-10398
[29]  
Tavassoli FA, 1992, PATHOLOGY BREAST, P27
[30]   Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome [J].
van de Rijn, M ;
Perou, CM ;
Tibshirani, R ;
Haas, P ;
Kallioniemi, C ;
Kononen, J ;
Torhorst, J ;
Sauter, G ;
Zuber, M ;
Köchli, OR ;
Mross, F ;
Dieterich, H ;
Seitz, R ;
Ross, D ;
Botstein, D ;
Brown, P .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (06) :1991-1996